EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis

Luiz H Guimarães iD, Evelyn Zacarias iD, Sandra T Nolasco, Almério N Filho, Jamile Lago, Paulo R L Machado, Joyce Oliveira, Lucas P Carvalho iD, Augusto Carvalho, Edgar M Carvalho iD, Sérgio Arruda iD

Pathogens · 2024

DOI: 10.3390/pathogens13111018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Luiz H Guimarães und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Service, University Hospital Professor Edgar Santos, Federal University of Bahia, Salvador 40110-160, Bahia, Brazil. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, CD8-Positive T-Lymphocytes, Granzymes, Skin Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian National Research Council (CNPq) Project #465229/2014-0 to E.M.C, Fundação Maria Emília Pedreira Freire de Carvalho Project #240020 to E.M.C, Fundaçã…, This work was supported by the Brazilian National Research Council (CNPq), Fundação Maria Emília Pedreira Freire de Carvalho.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous leishmaniasis (CL), caused by Leishmania braziliensis, is closely associated with a severe form of the disease, indicated by a positive Leishmania skin test (LST) that assesses and reflects the presence of immune T cells specific to Leishmania antigens. In this study, we compare the clinical, immunologic, and histopathologic features between Leishmania skin test-positive (LST+) and Leishmania skin test-negative (LST-) in CL. Compared to LST+ patients, LST- patients had larger lesions and had been sicker for longer, presented with more instances of therapeutic failure with meglumine antimonate, (MA) and the healing times were higher than LST+. While granulomas were less frequent and the parasite load was higher in LST-, there were more CD8+ T cells and an enhanced production of Granzyme B in the supernatants of biopsies from LST- subjects. This study shows that in LST-, an impairment in Th1 immune response is associated with a high parasite burden, and the pathology is mediated by CD8+ T cells and the enhanced production of Granzyme B. The abnormalities in the immunologic response in LST- patients lead to a more severe disease with a high rate of failure to therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, CutaneousCD8-Positive T-LymphocytesGranzymesSkin TestsLeishmania braziliensisMeglumine AntimoniateHumansFemaleMaleAdultMiddle AgedAntiprotozoal AgentsTreatment OutcomeYoung AdultParasite LoadMeglumineOrganometallic CompoundsAdolescentAged

Stichwörter der Autor:innen

GranzymeL. braziliensiscutaneous leishmaniasisdelayed-type hypersensitivity negativepathology

Substanzen

GranzymesMeglumine AntimoniateAntiprotozoal AgentsMeglumineOrganometallic Compounds

Autor:innen und Institutionen

  • Immunology Service, University Hospital Professor Edgar Santos, Federal University of Bahia, Salvador 40110-160, Bahia, Brazil.
  • Health Sciences Center, Santo Antonio de Jesus campus, Federal University of Recôncavo da Bahia, Santo Antônio de Jesus 44574-490, Bahia, Brazil.
  • National Institute of Science and Technology of Tropical Diseases (INCT-DT), MCTI CNPq, Salvador 40110-160, Bahia, Brazil.
  • Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador 40296-710, Bahia, Brazil.
  • Faculty of Pharmacy, Ondina Campus, Federal University of Bahia, Salvador 40170-115, Bahia, Brazil.
  • Department of Life Sciences, School of Medicine, Salvador Campus, State University of Bahia, Salvador 41200-105, Bahia, Brazil.

ORCID-Profile: Luiz H Guimarães, Evelyn Zacarias, Lucas P Carvalho, Edgar M Carvalho, Sérgio Arruda

Förderung

  • Brazilian National Research Council (CNPq) Project #465229/2014-0 to E.M.C, Fundação Maria Emília Pedreira Freire de Carvalho Project #240020 to E.M.C, Fundaçã…
  • This work was supported by the Brazilian National Research Council (CNPq)
  • Fundação Maria Emília Pedreira Freire de Carvalho
  • Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB)
  • PROEP- IGM-Fiocruz Bahia
  • R01 NIH

Zitieren

APA

Guimarães, L. H., Zacarias, E., Nolasco, S. T., Filho, A. N., Lago, J., Machado, P. R. L., Oliveira, J., Carvalho, L. P., Carvalho, A., Carvalho, E. M., & Arruda, S. (2024). The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis. Pathogens. https://doi.org/10.3390/pathogens13111018

Vancouver

Guimarães LH, Zacarias E, Nolasco ST, Filho AN, Lago J, Machado PRL, et al. The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis. Pathogens. 2024. doi:10.3390/pathogens13111018

BibTeX
@article{Guimares2024,
  author = {Guimarães, Luiz H and Zacarias, Evelyn and Nolasco, Sandra T and Filho, Almério N and Lago, Jamile and Machado, Paulo R L and Oliveira, Joyce and Carvalho, Lucas P and Carvalho, Augusto and Carvalho, Edgar M and Arruda, Sérgio},
  title = {The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13111018}
}
Kostenlos starten →